Showing 20 of 52 recruiting trials for “primary-localized-amyloidosis”
Exploratory Clinical Study on the Safety and Efficacy of Targeted BCMA Autologous CART Cell Injection in Subjects With Recurrent/Refractory Light Chain Amyloidosis
Multimodal Radiomics Model (18F-FAPI PET/CT + CMR) for AL Cardiac Amyloidosis Prognosis
RecruitingNCT06855121 ↗
The Norwegian Immunotherapy in Multiple Myeloma Study
Elranatamab in Patients With Relapsed or Refractory AL Amyloidosis
Daratumumab Combined With Venetoclax and Dexamethasone for Newly Diagnosed Light-Chain Amyloidosis With Translocation (11;14)
A Trial to Learn if Linvoseltamab is Safe and Works in Adults With Relapsed or Refractory Systemic Light Chain Amyloidosis (AL Amyloidosis)
DapagliFLOzin in Renal AL Amyloidosis (FLORAL)
👨⚕️ Jeffrey Zonder, M.D., Barbara Ann Karmanos Cancer Institute📍 1 site📅 Started Jul 2024View details ↗
Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis
Study of NXC-201 CAR-T in Patients With Light Chain (AL) Amyloidosis
Bortezomib, Pomalidomide, Dexamethasone for Systemic AL Amyloidosis
RecruitingNCT06365060 ↗
Screening for AL Amyloidosis in Smoldering Multiple Myeloma
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving Etentamig (ABBV-383) as an Intravenous (IV) Infusion
Daratumumab/Daratumumab and Hyaluronidase-fihj in Combination With Pomalidomide and Dexamethasone for the Treatment of Patients With Newly Diagnosed AL Amyloidosis: a Prospective, Multicenter, Single-arm Study
👨⚕️ Yongyong Ma, MD, First Affiliated Hospital of Wenzhou Medical University📍 1 site📅 Started Mar 2024View details ↗
Phase 1/2a Study of Belantamab Mafodotin in Relapsed or Refractory AL Amyloidosis
👨⚕️ Larry Anderson, MD, University of Texas Southwestern Medical Center📍 3 sites📅 Started Feb 2024View details ↗
Optimize First-line Treatment for AL Amyloidosis With t (11; 14)
RecruitingNCT06205953 ↗
A EUropean REgistry and Sample Sharing networK to Promote the Diagnosis and Management of Light Chain Amyloidosis (EUREKA)
FKC288 for Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis
Daratumumab Maintenance Therapy for Improving Survival in Patients With Light Chain Amyloidosis, EMILIA Trial
RecruitingNCT06383143 ↗
Promoting Diagnosis and Management of AL in Italy (ProDigALIty)
Efficacy of [18F]Florbetaben PET for Diagnosis of Cardiac AL Amyloidosis
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →